• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53抗原的过度产生会使成熟细胞具有高度致瘤性。

Overproduction of p53 antigen makes established cells highly tumorigenic.

作者信息

Eliyahu D, Michalovitz D, Oren M

出版信息

Nature. 1985;316(6024):158-60. doi: 10.1038/316158a0.

DOI:10.1038/316158a0
PMID:3892307
Abstract

The p53 cellular tumour antigen, long known to be overproduced in a variety of neoplastically transformed cells, was recently shown to be directly involved in transformation. Thus, p53 can complement activated Ha-ras in transforming secondary rat embryo fibroblasts into grossly altered, tumorigenic cells. Moreover, p53 can also be shown to possess immortalizing activity. Our previous results indicated, however, that the contribution of p53 to the transformation was not synonymous with immortalization, suggesting that the two activities of the protein are probably separable. We demonstrate here that this is indeed the case, as overproduction of p53 in an established cell line, while not causing gross morphological changes, endows these cells with an overt tumorigenic potential. Furthermore, the tumorigenic efficiency of such cell lines may be correlated with the extent of p53 over-production.

摘要

p53细胞肿瘤抗原长期以来已知在多种肿瘤转化细胞中过量产生,最近研究表明它直接参与细胞转化。因此,p53在将原代大鼠胚胎成纤维细胞转化为明显改变的致瘤细胞过程中可补充激活的Ha-ras的作用。此外,p53也具有永生化活性。然而,我们之前的结果表明,p53对转化的作用并不等同于永生化,这表明该蛋白的这两种活性可能是可分离的。我们在此证明确实如此,因为在一个已建立的细胞系中过量表达p53,虽然不会引起明显的形态学变化,但赋予这些细胞明显的致瘤潜能。此外,此类细胞系的致瘤效率可能与p53过量表达的程度相关。

相似文献

1
Overproduction of p53 antigen makes established cells highly tumorigenic.p53抗原的过度产生会使成熟细胞具有高度致瘤性。
Nature. 1985;316(6024):158-60. doi: 10.1038/316158a0.
2
Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.在已建立的成纤维细胞中过表达正常人p53会导致其发生致瘤性转化。
Oncogene Res. 1989;4(2):81-96.
3
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.细胞p53癌基因使大鼠胚胎成纤维细胞永生化。
Oncogene. 1988 May;2(5):445-52.
4
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.p53细胞肿瘤抗原在正常胚胎细胞转化中的作用。
Nature. 1984;312(5995):646-9. doi: 10.1038/312646a0.
5
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.编码p53肿瘤抗原的基因与ras在细胞转化中的协同作用。
Nature. 1984;312(5995):649-51. doi: 10.1038/312649a0.
6
Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.确定与Ha-ras转化的克隆大鼠胚胎成纤维细胞中致瘤和转移表型的表达及抑制相关的关键基因表达变化。
Oncogene. 1993 May;8(5):1211-9.
7
Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells.转录激活的人c-myc基因对大鼠3Y1细胞的肿瘤转化及转化细胞中p53细胞肿瘤抗原的稳定化
Mol Cell Biol. 1986 Dec;6(12):4379-86. doi: 10.1128/mcb.6.12.4379-4386.1986.
8
Meth A fibrosarcoma cells express two transforming mutant p53 species.
Oncogene. 1988 Sep;3(3):313-21.
9
The cellular oncogene p53 can be activated by mutagenesis.细胞癌基因p53可通过诱变激活。
Nature. 1985;317(6040):816-8. doi: 10.1038/317816a0.
10
p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.p53加ras转化的大鼠胚胎成纤维细胞表达肿瘤特异性移植抗原活性,这种活性为独立转化的细胞所共有。
J Virol. 1989 Dec;63(12):5440-4. doi: 10.1128/JVI.63.12.5440-5444.1989.

引用本文的文献

1
TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review).TP53 基因突变与癌症:分子特征与治疗机会(综述)。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5448. Epub 2024 Oct 25.
2
Concepts in B cell acute lymphoblastic leukemia pathogenesis.B细胞急性淋巴细胞白血病发病机制中的概念
J Leukoc Biol. 2024 Jun 28;116(1):18-32. doi: 10.1093/jleuko/qiae015.
3
Targeting p53 pathways: mechanisms, structures, and advances in therapy.靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
4
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.千面蛋白:p53的肿瘤抑制与致癌反应
Front Mol Biosci. 2022 Aug 25;9:944955. doi: 10.3389/fmolb.2022.944955. eCollection 2022.
5
Shifting the paradigms for tumor suppression: lessons from the p53 field.肿瘤抑制的范式转变:来自 p53 领域的启示。
Oncogene. 2021 Jun;40(25):4281-4290. doi: 10.1038/s41388-021-01852-z. Epub 2021 Jun 8.
6
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.抑癌基因 p53:生物学、信号通路和治疗靶点。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188556. doi: 10.1016/j.bbcan.2021.188556. Epub 2021 Apr 29.
7
Extracellular Vesicles: Messengers of p53 in Tumor-Stroma Communication and Cancer Metastasis.细胞外囊泡:肿瘤-基质通讯和癌症转移中 p53 的信使。
Int J Mol Sci. 2020 Dec 17;21(24):9648. doi: 10.3390/ijms21249648.
8
p53: not just a tumor suppressor.p53:不仅仅是一种肿瘤抑制因子。
J Mol Cell Biol. 2019 Jul 19;11(7):539-543. doi: 10.1093/jmcb/mjz070.
9
Updates from the TP53 universe.来自TP53领域的最新消息。
Cell Death Differ. 2018 Jan;25(1):10-12. doi: 10.1038/cdd.2017.190. Epub 2017 Nov 10.
10
Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.突变型 p53 通过 microRNAs 及其靶基因网络发挥致癌作用。
FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12.